Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
Phentermine primarily affects the hypothalamus, part of the inner brain
From trademark battles to claims of unsafe compounding, heres a full breakdown of the l You will not believe the GLP-1 lawsuit tea Fake doctors
Ideal for people with demanding lifestyles who want maximum power, but also for those who want to take care of their musculature, athletes or those who exercise
For individuals coping with ADHD or binge eating disorder, Vyvanse can be a useful tool to manage symptoms
Some users report subtle improvements within days, while others notice more significant changes after several weeks of consistent use